Related Experiment Video
Updated: Jan 10, 2026

Urokinase-type Plasminogen Activator-induced Mouse Back Pain Model
Published on: September 1, 2023
Myocardial Infarction in a Patient With Homozygous Plasminogen Activator Inhibitor-1 (PAI-1) 4G/4G Mutation: A Case
AlMothana Manasrah1, Farid Khan2, Alon Yarkoni2
1Department of Internal Medicine, United Health Services, Wilson Medical Center, Johnson City, USA.
A rare case of myocardial infarction in a 47-year-old male was linked to the plasminogen activator inhibitor-1 (PAI-1) 4G/4G gene polymorphism, a type of thrombophilia. This highlights the need for thrombophilia testing in young patients with acute coronary syndrome.
Area of Science:
- Cardiology
- Genetics
- Thrombosis
Background:
- Non-ST-elevation acute coronary syndrome (NSTE-ACS) is rarely caused by genetic thrombophilias.
- Plasminogen activator inhibitor-1 (PAI-1) polymorphisms are known genetic risk factors for thrombosis.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

